On May 15, 2026, SURG reported earnings of -0.51 USD per share (EPS) for Q1 26, missing the estimate of -0.19 USD, resulting in a -163.16% surprise. Revenue reached 15.98 million, compared to an expected 15.80 million, with a 1.13% difference. The market reacted with a -6.87% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 4 analysts forecast an EPS of -0.11 USD, with revenue projected to reach 14.08 million USD, implying an decrease of -78.43% EPS, and decrease of -11.94% in Revenue from the last quarter.